Search Videos and More
News
Fox Chase Researchers Present Findings on BRCA-Mutated Breast Cancer at American Society for Radiation Oncology Meeting
Course
2023 State-of-the -Art Treatment for Early Stage Lung Cancer
The program will focus on the latest research and strategies for optimally managing early stage NSCLC patients, including detection, imaging, diagnosis, staging, and treatment.
Course
Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies
Join us for this in-person educational program, presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education. The program will cover the latest strategies for optimally managing localized and advanced bladder, kidney and prostate cancer from the Fox Chase Cancer Center genitourinary oncology team—nationally recognized physicians specializing in urology, radiation therapy, and medical oncology.
Video
The Role of Locoregional and Systemic Therapies in the Management of Colorectal Liver Metastases
In this video, Dr. Castellanos explains the role of surgical resection in the management of liver-confined metastatic colorectal cancer and using hepatic artery infusion pump (HAIP) chemotherapy for treating resectable and unresectable colorectal liver metastases.
News
A One-Stop Shop for Liver Cancer
Fox Chase Improves Treatment and Access to It
News
Residency & Fellowship. . . to Leadership
Why do many GI Fox Chase Fellow and Residents stay at Fox Chase after training? Hear what a few say about starting and staying here because of the exceptional clinical, research, and leadership opportunities.
News
The World is Dr. Perkins’ Patient
Julia Perkins Smith, MD, Oncology Global Clinical Lead at Pfizer, is a hematologist-oncologist, strategist, and solution seeker -- at the helm of developing breakthrough therapies for breast cancer patients worldwide and implementing clinical trials to examine their efficacy and safety.
Symposium
New Directions in the Diagnosis and Treatment of Hematologic Cancers: Highlights from International Medical Meetings
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, these enduring materials review cutting-edge updates and perspectives on new diagnostic tools and management options of hematologic malignancies. Courses include genetic profiling, cytogenetics, molecular diagnostics, risk adaptive strategies, and novel therapies recently approved by the FDA.
News
Temple Health Launches New Fox Chase-Temple Urologic Institute
Fox Chase Cancer Center and Temple Health are pleased to announce the new Fox Chase-Temple Urologic Institute, a groundbreaking initiative that will concentrate on both benign and oncologic urology.
Course
New Directions in the Diagnosis and Treatment of Hematologic Cancers: Highlights from International Medical Meetings
This symposium will provide attendees with cutting-edge updates and perspectives on new diagnostic tools and management options of hematologic malignancies including genetic profiling, cytogenetics, molecular diagnostics, riskadaptive strategies, and novel therapies recently approved by the FDA.
News
Comprehensive Cancer Care Demands Exceptional Teamwork, Collaboration and Leaders to Bring It to Life.
Centralizing scientific discovery, advanced research, and clinical care—all for a new therapeutic pathway.
News
New Fox Chase Clinical Trial Could Help Men With Intermediate-Risk Prostate Cancer Avoid Radical Treatment
Could NanoKnife be the future of prostate cancer care?